| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, March 2007, p. 1203-1213, Vol. 75, No. 3
0019-9567/07/$08.00+0 doi:10.1128/IAI.01702-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Institute of Molecular Biology, University of Oregon, Eugene, Oregon
Received 24 October 2006/ Returned for modification 7 December 2006/ Accepted 14 December 2006
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The H. pylori-host cell interaction is often modeled in vitro by coculture with a human gastric adenocarcinoma cell line, AGS. In AGS cells, CagA delivery and the subsequent altered cell signaling result in a dramatic actin-dependent cell morphological change known as the "hummingbird" phenotype, in which cells are transformed from a uniform polygonal shape into a severely elongated state characterized by the formation of needle-like projections (48). The hummingbird phenotype is strictly dependent on delivery of CagA into host cells and its subsequent tyrosine phosphorylation by host kinases, as demonstrated by the fact that cells infected with H. pylori lacking CagA, infected with H. pylori with a mutated CagA that cannot be phosphorylated, or treated with the Src kinase inhibitor PP2 do not elongate (3, 21, 48, 49). Additionally, this phenotype appears to be dependent on phosphorylated CagA's interaction with SHP-2 (22, 25). H. pylori infection also induces scattering in AGS cells, which is distinct from the hummingbird elongation phenotype in that it is at least partially CagA independent (1, 39). In MDCK cells, a polarized epithelial cell line, CagA-expressing cells lose their polarity, detach from their neighbors, and become motile with a phenotype reminiscent of an epithelial-to-mesenchymal transition, a process known to be important in metastasis (4). Therefore, understanding CagA's induction of cell morphological changes is critical for understanding CagA's link to cancer.
The needle-like projections which define the hummingbird phenotype are reminiscent of cellular structures such as neurite outgrowths and filapodium protrusions. Formation of these structures requires actin polymerization via the Arp2/3 complex and is often regulated by the Rho GTPases Cdc42 and Rac1. The Rho family GTPases Cdc42 and Rac1 are key mediators of actin dynamics that control cytoskeleton-based movement via signaling to the Arp2/3 complex through their downstream effectors N-WASP and WAVE, respectively (28, 44, 65, 66). Cdc42 and Rac1 signaling cascades are hijacked by several important human pathogens, both viral and bacterial, as part of their infectious life cycles (for reviews, see references 17 and 18). For example, the enteric pathogen Salmonella enterica serovar Typhimurium injects SopE and SopE2 effector proteins into host cells, which directly activate Cdc42 and Rac1 to induce membrane ruffling and bacterial uptake into nonphagocytic cells (9). Utilizing another mechanism, Listeria monocytogenes recruits Arp2/3 directly on the bacterial surface to initiate actin polymerization for intracellular motility and intercellular spread (63).
Previous studies have hinted that H. pylori's effector protein CagA may induce the elongation phenotype through Cdc42 and Rac1 pathways as well. In one study, H. pylori infection was reported to stimulate Cdc42 and Rac1 activation and cause dramatic changes in the localization of these proteins, although these effects were dependent on an intact TFSS but independent of CagA delivery (11). In a DNA microarray study, we found that Cdc42 and its downstream effector, Cdc42 effector protein 2 (CEP2), were up-regulated in a CagA-specific manner (19). Additionally, the H. pylori-induced cell scattering phenotype appears to be dependent upon Rac1 signaling, although this study did not address cell elongation (53).
We hypothesized that the cytoskeletal rearrangements associated with the hummingbird cell elongation phenotype are Arp2/3-dependent, Cdc42- and Rac1-regulated events. However, our data refute this model and instead point to a new cellular mechanism of CagA-induced cell elongation which is likely to involve a set of molecular mechanisms different from the molecular mechanisms hypothesized previously.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1.0 with agitation in anaerobe jars with Campygen packets (Oxoid) to supply a microaerophilic atmosphere. Just prior to infection, AGS cells were transferred to infection medium, H. pylori was added at a multiplicity of infection (MOI) of 100, the cultures were incubated for 15 min, and then nonadherent bacteria were removed with one change of medium. S. enterica serovar Typhimurium strain SL1344 expressing green fluorescent protein (GFP) (61) was a gift from Corrie Detweiler (University of Colorado, Boulder) and was grown in Luria broth (Difco). L. monocytogenes strain 10403S was a gift from Daniel Portnoy (University of California, Berkeley) and was grown in blood heart infusion medium (Difco). Antibodies. For immunofluorescence experiments, cells were fixed for 10 min in 2% paraformaldehyde in 37.5 mM phosphate buffer with 750 mM lysine and 10 mM periodate and were permeabilized in blocking buffer (3% bovine serum albumin and 1% saponin in phosphate-buffered saline [PBS]) unless indicated otherwise. Chicken anti-GFP (Chemicon International) was used at a 1:2,500 dilution, and both mouse anti-H. pylori (MonoSan) and mouse anti-vinculin (Sigma) were used at a 1:200 dilution. Rabbit anti-Cdc42 (Santa Cruz) and mouse anti-Rac1 (Upsate) were used at a 1:100 dilution. To optimize visualization of Cdc42 localization, cells were first fixed in 4% paraformaldehyde-2% acetic acid for 2 min and then in 95% ethanol-5% acetic acid for 15 min, and then they were blocked in 8% bovine serum albumin in PBS before application of antibodies. Cy2 anti-chicken, Cy2 anti-mouse, Cy3 anti-rabbit (Jackson Immunologicals), Cy2 anti-rabbit, and Cy3 anti-mouse (Sigma) antibodies were used at a 1:200 dilution. Actin was visualized using tetramethyl rhodamine isocyanate, fluorescein isothiocyanate (Sigma), and Alexa Fluor 633-conjugated phalloidin (Molecular Probes) at dilutions of 1:500, 1:500, and 1:40, respectively.
For Western blotting, mouse anti-Rac1 (Upstate) was used at a 1:1,000 dilution, and mouse anti-Cdc42 (BD Transduction Labs) was diluted 1:250. Sheep anti-mouse and donkey anti-rabbit horseradish peroxidase-conjugated antibodies (Amersham Bioscience) were used at a 1:2,000 dilution.
DNA constructs.
A plasmid for expression of the Cdc42/Rac interaction binding (CRIB) domain of p21-activated kinase fused to glutathione S-transferase (GST-CRIB) was kindly provided by Barbara Kazmierczak (originally from Richard Cerione, Cornell University, Ithaca, NY). Templates for Cdc42 and Rac1 N17 dominant negative mutants were kindly provided by Daniel Kalman (Emory University). WAVE1 template was provided by Shiro Suetsugu (University of Tokyo) and was used to create WAVE1
VPH (36). WAVE2
VPH (52) was created using cDNA from Open Biosystems (catalog no. MSH101-9204726), and N-WASP cDNA was obtained from the ATCC (catalog no. 10435323) and was used to create N-WASP
VCA (amino acids 1 to 390) or the VCA domain alone (amino acids 391 to 507). These DNA constructs were cloned into pEGFP-C3 (Stratagene) for expression with N-terminal GFP fusions in mammalian cells. CEP2 was PCR amplified from AGS cell cDNA with a myc N-terminal tag and cloned into pcDNA3 (Invitrogen).
Cdc42/Rac1 activation assays. AGS cells were grown to confluence in 15-cm dishes. The medium was changed to infection medium, and cells were equilibrated for 3 h before addition of H. pylori at an MOI of 1:50. Cells were also infected with S. enterica serovar Typhimurium at an MOI of 1:50 in parallel experiments as a control. At different times, cells were washed once with ice-cold PBS and scraped into 750 µl of ice-cold lysis buffer (50 mM Tris-HCl [pH 7.5], 100 mM NaCl, 2 mM MgCl2, 1 mM dithiothreitol, 1 mM ortho-vanadate, 10% glycerol, 1% NP-40, Complete protease inhibitor cocktail [Roche Bioscience]) containing 75 µl of GST-CRIB crude Escherichia coli lysate. Lysis was completed by four passages through a 23-gauge needle. Lysates were precleared by centrifugation at 4°C; then 50 µl was set aside for total Rho GTPase determination, and the remainder was incubated with glutathione agarose (Sigma) to capture GST-CRIB complexes. After three washes in excess lysis buffer, the protein was eluted from beads by boiling in 2x sodium dodecyl sulfate (SDS) sample buffer (125 mM Tris-HCl [pH 6.8], 20% glycerol, 2% SDS, 0.01% bromophenol blue), separated by SDS-polyacrylamide gel electrophoresis, and then transferred to a Hybond-P membrane (Amersham Bioscience) for Western blotting and detection via enhanced chemiluminescence with the ECL Plus detection reagent (Amersham Bioscience). Bands were visualized with a Storm 860 phosphorimaging system (Amersham Bioscience) and were quantified using the ImageQuant software (Molecular Dynamics).
Cell elongation assays. Cell elongation assays were performed as described previously (8). Briefly, AGS cells were seeded on glass coverslips and were transfected the next day using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. The transfection efficiency with AGS cells varied widely between 10% and 90% in a construct-dependent manner (unpublished observations). Cells were infected 24 h later at an MOI of 1:100, and the preparations were incubated for 6 h. In select experiments, cells were treated with 50 µM PP2 (Calbiochem) concurrent with addition of bacteria. Coverslips were very gently rinsed once with plain DMEM and then fixed and stained to visualize cells containing epitope-tagged proteins. Images of approximately 50 random fields of view at a magnification of x200 were obtained using a Nikon TE2000 inverted microscope. The images were analyzed using Metamorph software to obtain length and breadth data for at least 200 transfected cells per condition.
Gentamicin protection assay. Gentamicin protection assays were performed essentially as described previously (2). AGS cells grown in six-well dishes were pretreated for 40 h with dimethyl sulfoxide (DMSO) alone or freshly reconstituted 10 µM GGTI-298 (Calbiochem). Confluent cells were then infected with H. pylori. Four hours after addition of bacteria, the medium was removed and replaced with normal infection medium (for counting total H. pylori) or infection medium supplemented with 200 µg/ml gentamicin (for counting internalized H. pylori). After an additional 4 h, cells were washed with two changes of medium to remove nonadherent extracellular bacteria and then scraped into and lysed in plain DMEM supplemented with 1% saponin before serial dilution and plating on blood agar for colony counting.
L. monocytogenes comet tail assay. AGS cells were transfected 24 h before infection with GFP alone or GFP-VCA. L. monocytogenes was grown overnight at 30°C without shaking in blood heart infusion medium. Bacteria were then washed once in PBS and added to AGS cells at a dilution of 1:100 in DMEM containing 10% fetal bovine serum without antibiotics. One hour later, cells were washed three times with fresh medium to remove nonadherent bacteria. The cultures were incubated for another 30 min before gentamicin was added at a final concentration of 50 µg/ml. Internalized bacteria were then allowed to form comet tails for 5 h before fixation and processing for immunofluorescence analysis.
Time-lapse video microscopy. AGS cells were plated in four-well glass bottom Chamberwell slides (LabTek) and grown to 90% confluence. Immediately before the experiment, a pipette tip was used to scrape away cells and establish a central zone of sparse cells surrounded by a dense periphery, and then cells were infected as described above for cell elongation assays. PP2 was used at a concentration of 50 µM. A microaerophilic atmosphere was created in the wells by addition of an oxygen-sequestering enzyme (Oxyrase) at a 1:1,000 dilution before the chamber was sealed with a mineral oil overlay. Images were captured every 7 min for 9 h on a temperature-controlled stage adapted to the Nikon TE2000 inverted microscope.
| RESULTS |
|---|
|
|
|---|
|
Churin et al. also reported that Cdc42 and Rac1 proteins relocalize to the points of bacterial attachment on AGS cells infected with cagA H. pylori mutants but not on AGS cells infected with TFSS H. pylori mutants derived from strain P1 (11). We tested whether we could observe the relocalization of Cdc42 and Rac1 under our infection conditions with strain G27 that resulted in cell elongation.
AGS cells were infected with H. pylori for 3 or 6 h and stained to reveal bacteria and Cdc42 or Rac1. Uninfected cells and cells infected with S. enterica serovar Typhimurium SL1344 for 45 min as controls represented basal and activated conditions, respectively. We chose S. enterica serovar Typhimurium infection as a positive control because we observed robust Cdc42 and Rac1 activation under these conditions (Fig. 1C) and because S. enterica serovar Typhimurium infection of polarized MDCK cells reportedly causes apical accumulation of these proteins (55). To ensure that the staining patterns that we observed were not due to nonspecific binding by the secondary antibodies, we performed control experiments in which the primary antibodies were omitted, which eliminated all staining of any cellular structures (data not shown). In our experiments, the localization of both Cdc42 and Rac1 remained unchanged under all conditions, even when cells were infected with S. enterica serovar Typhimurium. Cdc42 was always observed surrounding the nuclear envelope in the region of the endoplasmic reticulum and Golgi apparatus (Fig. 2A to D). This localization pattern is in accordance with observations described by other workers for nonpolarized cells (16, 35). Perinuclear localization was also observed for Rac1 in addition to staining along the lamellipodia (Fig. 2E to H), which is also consistent with previous observations (15). Although cells were covered with attached H. pylori by 6 h postinfection (Fig. 2C, D, G, and H), there was no distinct pattern of bacterial colocalization with either Cdc42 or Rac1.
|
|
Next, we tested whether dominant negative alleles of Cdc42 and Rac1 could block H. pylori-induced cell elongation. The average L/B ratio for cells expressing GFP-Cdc42(N17) or GFP-Rac1(N17) and infected with H. pylori was found to be 1.3-fold greater than the average L/B ratio for uninfected controls, similar to the results obtained for GFP-transfected cells (Fig. 3C and D). Identical results were obtained using myc rather than GFP-tagged alleles that were expressed from a different mammalian expression vector (not shown). We concluded that Cdc42 or Rac1 inhibition alone is not sufficient to block the hummingbird phenotype.
Cdc42 and Rac1 can function redundantly, as demonstrated by the observation that inhibition of Cdc42 or Rac1 alone attenuates but does not completely inhibit S. enterica serovar Typhimurium invasion (59). In our transfection assays we were limited to inhibition of only one pathway at a time and could not exclude the possibility that CagA-induced elongation, like S. enterica serovar Typhimurium invasion, occurs through either Cdc42 or Rac1 pathways. Therefore, we wanted to test conditions in which both Cdc42 and Rac1 were simultaneously inhibited. Rho family GTPases, including Cdc42 and Rac1, undergo prenylation with a geranylgeranyl moiety through the activity of geranylgeranyl transferase. This modification is required for Rho GTPase localization to the plasma membrane and participation in normal signaling (65). GGTI-298 is a specific and selective inhibitor of geranylgeranyl transferase at a concentration of 10 µM (62). Therefore, we used GGTI-298 to inhibit Rho GTPases in AGS cells and assayed aspects of the AGS response to H. pylori infection.
Although H. pylori remains predominantly extracellular during coculture with tissue culture cells, a small H. pylori population is internalized. This phenotype is independent of the cag PAI but dependent on host cell actin networks (2, 30, 41). We found that the ability of GGTI-298-treated AGS cells to internalize H. pylori was reduced by nearly an order of magnitude (Fig. 3E). Thus, our results indicated that the GGTI-298 inhibitor was effective at blocking at least one host cell activity thought to be dependent on actin cytoskeleton dynamics.
Next, we tested whether GGTI-298 treatment of AGS cells blocked H. pylori-induced cell elongation. GGTI-298-treated cells were much more susceptible to H. pylori-induced cell death and were also resistant to transfection and thus not amenable to analysis using our length-to-breadth ratio assay (data not shown). However, as determined by differential interference contrast microscopy, we observed no difference in elongation in response to H. pylori infection between GGTI-298-treated cells and cells treated with DMSO alone (Fig. 3F). Based on these findings together with our data obtained from infection of cells expressing dominant negative Rho GTPases, we concluded that cell elongation is independent of the activity of Cdc42 and Rac1.
Effector proteins downstream of Cdc42 and Rac1 are not required for elongation.
Although our experiments did not uncover any role for Cdc42 and Rac1 in H. pylori-induced cell elongation, we wondered if CagA could directly manipulate the downstream effectors of these small Rho GTPases. During normal signaling, activated GTP-bound Cdc42 and Rac1 bind to their effectors N-WASP and WAVE, respectively. These proteins contain C-terminal veprin and cofilin homology regions and acidic domains (termed VCA in N-WASP and VPH in WAVE), which mediate interactions with actin and the Arp2/3 complex (37). In this way, both Cdc42 and Rac1 signal through parallel pathways to initiate actin polymerization via Arp2/3. C-terminal truncations of these proteins lacking the VCA or VPH domain are unable to bind Arp2/3 and act in a dominant negative manner (36, 40). Therefore, we transfected cells with a
VCA mutant of N-WASP and two WAVE isoforms (WAVE1
VPH and WAVE2
VPH) in our transfection and elongation assay. Again, we found that the dominant negative constructs had no effect on H. pylori-induced cell elongation (data not shown).
We also tested another downstream effector of Cdc42, CEP2, which we identified as a molecule that was strongly up-regulated in AGS cells in response to CagA delivery (19). Overexpression of CEP2 was reported to cause cell elongation in NIH-3T3 cells, and this activity was dependent on CEP2's ability to bind Cdc42 through its CRIB domain (26). We tested whether CEP2 expression in AGS cells could phenocopy CagA-induced cell elongation. Uninfected cells overexpressing CEP2 were compared to cells expressing GFP and cells expressing GFP that were infected with H. pylori. We found that CEP2 caused a modest but statistically significant increase in the average L/B ratio (Fig. 4A). However, CEP2-induced elongation did not phenocopy H. pylori infection either in magnitude (Fig. 4A) or in cell morphology (Fig. 4B). CEP2-transfected cells were indeed longer than GFP-transfected cells, but they lacked the extremely long needle-like projections observed in H. pylori-infected cells (Fig. 4B). We concluded that CEP2 signaling is not sufficient to cause the same elongation phenotype as the phenotype induced by H. pylori.
|
The bacterial pathogen L. monocytogenes polymerizes actin on its surface, enabling it to move within host cells and facilitate intracellular spread via activation of the Arp2/3 complex (63). The resulting actin comet tails can be blocked by inhibition of Arp2/3 via overexpression of VCA (34). We transfected cells with GFP alone or GFP fused to the VCA domain of N-WASP (GFP-VCA) and then infected the cells with L. monocytogenes 1043S. We observed comet tails in about 15% of the AGS cells transfected with GFP. However, the level of comet tail formation was 5% in cells expressing GFP-VCA (Fig. 5A and B). This level of comet tail formation inhibition is similar to the level seen when RNA interference silencing of the Arp2 complex was used, which is another effective method of blocking Arp2/3 function (14), and demonstrated that the N-WASP VCA domain significantly reduced Arp2/3 activity in AGS cells. We then tested whether inhibition of Arp2/3 in AGS cells blocked H. pylori-induced cell elongation. We found that the average L/B ratio of AGS cells expressing the GFP-VCA construct increased approximately 1.3-fold in the presence of H. pylori (Fig. 5C), which was similar to the effect on cells transfected with GFP alone (Fig. 3B and 4D). Therefore, we concluded that H. pylori-induced cell elongation is Arp2/3 independent.
|
|
|
To quantify this phenomenon, we monitored the protrusive and retractile behavior of the 54 individual cells analyzed in Fig. 7A to D. We first counted the number of frames during which a cell exhibited protrusive morphology, defined as an increase in cell surface area in the direction of cell movement between frames. Cells infected with H. pylori underwent slightly more protrusion events than uninfected cells underwent (Fig. 7E). We next counted retraction events in the same cells (a retraction event was defined as a decrease in the cell surface area between frames in the direction of cell movement) and found that infected AGS cells underwent far fewer retraction events than control cells underwent (Fig. 7F). Thus, we concluded that the hummingbird elongation phenotype is a result of a cell retraction defect.
Focal adhesions (FA) are large, multiprotein complexes that mediate interactions between cells and the substrate to which they adhere. Disassembly of FA at the cell's distal end is a crucial step in cell translocation (45). If our hypothesis that the hummingbird phenotype results from a retraction defect is correct, then we should observe focal adhesions inappropriately stabilized in the distal tips of cell protrusions. We examined the distribution of the FA in AGS cells by staining cells with an antibody to the FA component vinculin. We asked whether the locations of FA were different in infected and uninfected cells. Uninfected cells generally were polygonal and were decorated with FA complexes on the peripheral, basal surface (Fig. 8A). In contrast, the projections of infected cells showed no FA complexes along the length. Significantly, we observed FA complexes at the distal tips of cell projections. Based on our live imaging analysis showing that these cell projections are formed from the back ends of migrating cells, we interpreted the vinculin distribution as validation of our model that the hummingbird phenotype arises from a failure to disassemble FA at the cell uropod during cell migration (Fig. 8B and C).
|
| DISCUSSION |
|---|
|
|
|---|
As a first test of Rho GTPase signaling during H. pylori infection, we looked for changes in the activity or localization of these proteins during an elongation time course. We were able to detect Cdc42 and Rac1 activation in AGS cells infected with S. enterica serovar Typhimurium, but this assay could not detect similar activation in an H. pylori infection, nor did we observe relocalization of Cdc42 and Rac1 under conditions in which they were activated (when cells were infected with S. enterica serovar Typhimurium). Our analysis of Rho GTPase cellular distribution is consistent with other reports of nonpolarized cells indicating that total Rho GTPase localization does not correlate with GTP- or GDP-bound status and does not shift under GTPase-stimulating conditions (43). Subtle relocalization of a small subset of GFP-Rho GTPase fusion proteins in response to known stimulatory signals has been detected by high-resolution methods (15). In other studies workers have utilized fluorescence resonance energy transfer to track the fleeting changes in activated subsets of the GTPase pool with GFP-fused effectors (27, 29, 43). We attempted to use S. enterica serovar Typhimurium as a positive control for Cdc42 and Rac1 localization based on a previous report with MDCK cells that infection with this bacterium results in apical accumulation of these proteins (55). We observed no such localization change in our AGS cells, but AGS cells are nonpolarized and thus physiologically very different from MDCK cells. It is not clear why there is a discrepancy between our results and the results of Churin et al., who reported cag PAI-dependent but CagA (and thus elongation)-independent activation and change in localization of these proteins (11). It is possible that due to heterogeneity among H. pylori isolates, the strain that we tested (G27) lacks an as-yet-unidentified effector molecule responsible for Rho GTPase activation and localization. Such a putative effector, however, would not be required for the induction of cell elongation, which was first described using the G27 strain (48).
Next, we tested a variety of inhibitors of signaling pathways that lead to Arp2/3-dependent actin polymerization and showed that Rho GTPase pathways and the Arp2/3 complex itself are dispensable for the elongation phenotype. We recognize the possibility that redundancy of Rho GTPases or incomplete inhibition by the dominant negative constructs could explain the persistence of H. pylori-induced elongation in the treated cells. However, under conditions where our reagents inhibited other actin-based phenomena (H. pylori entry into AGS cells and L. monocytogenes intracellular movement), we observed no effect on H. pylori-induced cell elongation. Our finding that Arp2/3-depleted cells were still motile is consistent with a recent report that Arp2/3 activity is dispensable for cell motility in fibroblasts (14).
At first glance, our results appear to be in conflict with the finding that CagA-induced cell scattering is mediated by Rac1 signaling through WAVE (53). However, in their study Suzuki et al. directly measured only cell scattering, not elongation, although they used the two terms interchangeably. Here we defined elongation as the hummingbird phenotype originally described by Segal et al. (48). Multiple reports attest to the fact that cellular elongation and cell scattering are two distinct phenotypes. Cell elongation is strictly dependent on CagA delivery and tyrosine phosphorylation (23, 39, 48; this study). Cell scattering appears to be an intrinsic property of AGS cells grown in serum (Fig. 6A and 7A); under some conditions it is enhanced by H. pylori infection but is only partially dependent on CagA activity (1, 39). Our method of measuring the elongation phenotype relies on the quantitative and unambiguous metrics of cell length and breadth, and it scores only the subset of cells that are transfected (8). In other studies workers used a qualitative rather than quantitative measure of cell shape, and in some cases, they did not distinguish between transfected cells expressing the protein of interest and nontransfected neighbors (1, 22-25, 39, 57).
Our finding that H. pylori induces elongation via a cell retraction defect is supported by the recent observations of Tsutsumi et al., who identified focal adhesion kinase (FAK) as a downstream target of CagA-activated SHP-2 (57). In the experiments of these workers, transfection of AGS cells with wild-type CagA caused a decrease in FAK tyrosine phosphorylation. Tsutsumi et al. proposed that a decrease in FAK activity led to an increase in focal adhesion turnover and thus greater cell motility, although they did not investigate cell movement in real time. Interestingly, they noted that although FAK activity decreased overall in cells expressing CagA, a pool of activated FAK in FA remained at the distal tips of cell extensions. FAK acts upon many substrates and can promote both FA assembly and disassembly (38, 42). FAK is also a direct target of the c-Met receptor tyrosine kinase and c-Src (10), both of which are key players in CagA signaling (7). Based on our finding that elongation is due to a cell retraction defect, we hypothesize that FAK stabilizes FA in the distal tips of elongating cells.
So far, the cell retraction defect induced by H. pylori CagA is unique among bacterial pathogens both in its Arp2/3-independent mechanism (18) and in its cellular phenomenology. However, the phenotype is reminiscent of the morphological change observed in epithelial cells following infection with vaccinia virus (46, 47). The vaccinia virus-induced phenotype is dependent upon suppression of RhoA signaling to Rho-associated kinase (ROCK) by the viral protein F11L (60). ROCK phosphorylates and activates myosin light chain of myosin II, an actin binding motor protein (33). Inhibition of ROCK with the chemical inhibitor Y-27632 leads to an elongated cell phenotype, likely through inhibition of myosin II phosphorylation (56). This has also been observed in myosin-null Dictyostelium that has a retraction defect during motility (58). We also found that direct inhibition of myosin II in AGS cells with blebbistatin, a specific inhibitor of the motor ATPase (51), results in an elongated cell phenotype reminiscent of H. pylori infection (unpublished observations). Furthermore, FAK is regulated by many of the same pathways that regulate myosin II activity. We attempted to use constitutively activated RhoA, constitutively active myosin light chain (56), and the catalytic domain of ameba PAK (54) to investigate the role of myosin II in CagA-induced AGS cell elongation. However, manipulation of these pathways appeared to cause a general loss of cellular adhesion, which confounded our L/B analysis (data not shown). Therefore, the role of myosin II in the CagA-induced retraction defect, if any, may be best explored in a different model system. Our studies with AGS cells have allowed us to rule out the hypothesis that the Cdc42/Rac1 and Arp2/3 pathways are pathways that contribute to the hummingbird phenotype. Our real-time imaging of H. pylori-infected cells demonstrated that the hummingbird phenotype is caused instead by a cell retraction defect and indicated that different molecular pathways are likely to be the target of CagA signaling in epithelial cells.
| ACKNOWLEDGMENTS |
|---|
K.G. is a recipient of a Burroughs Wellcome Fund Career Award in the Biomedical Sciences and was supported by Research Scholar Grant RSG-03-101-01-MBC from the American Cancer Society and by NIH grant R56 DK075667-01.
| FOOTNOTES |
|---|
Published ahead of print on 28 December 2006. ![]()
Supplemental material for this article may be found at http://iai.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
| 1. | Al-Ghoul, L., S. Wessler, T. Hundertmark, S. Kruger, W. Fischer, C. Wunder, R. Haas, A. Roessner, and M. Naumann. 2004. Analysis of the type IV secretion system-dependent cell motility of Helicobacter pylori-infected epithelial cells. Biochem. Biophys. Res. Commun. 322:860-866.[CrossRef][Medline] |
| 2. | Amieva, M. R., N. R. Salama, L. S. Tompkins, and S. Falkow. 2002. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cell. Microbiol. 4:677-690.[CrossRef][Medline] |
| 3. | Backert, S., S. Moese, M. Selbach, V. Brinkmann, and T. F. Meyer. 2001. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol. Microbiol. 42:631-644.[CrossRef][Medline] |
| 4. | Bagnoli, F., L. Buti, L. Tompkins, A. Covacci, and M. R. Amieva. 2005. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl. Acad. Sci. USA 102:16339-16344. |
| 5. | Benard, V., B. P. Bohl, and G. M. Bokoch. 1999. Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J. Biol. Chem. 274:13198-13204. |
| 6. | Blaser, M. J., and J. C. Atherton. 2004. Helicobacter pylori persistence: biology and disease. J. Clin. Investig. 113:321-333.[CrossRef][Medline] |
| 7. | Bourzac, K. M., and K. Guillemin. 2005. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell. Microbiol. 7:911-919.[CrossRef][Medline] |
| 8. | Bourzac, K. M., L. A. Satkamp, and K. Guillemin. 2006. The Helicobacter pylori cag pathogenicity island protein CagN is a bacterial membrane-associated protein that is processed at its C terminus. Infect. Immun. 74:2537-2543. |
| 9. | Chen, L. M., S. Hobbie, and J. E. Galan. 1996. Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 274:2115-2118. |
| 10. | Chen, S. Y., and H. C. Chen. 2006. Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion. Mol. Cell. Biol. 26:5155-5167. |
| 11. | Churin, Y., E. Kardalinou, T. F. Meyer, and M. Naumann. 2001. Pathogenicity island-dependent activation of Rho GTPases Rac1 and Cdc42 in Helicobacter pylori infection. Mol. Microbiol. 40:815-823.[CrossRef][Medline] |
| 12. | Covacci, A., S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Macchia, A. Massone, E. Papini, Z. Xiang, N. Figura, et al. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 90:5791-5795. |
| 13. | Criss, A. K., D. M. Ahlgren, T. S. Jou, B. A. McCormick, and J. E. Casanova. 2001. The GTPase Rac1 selectively regulates Salmonella invasion at the apical plasma membrane of polarized epithelial cells. J. Cell Sci. 114:1331-1341.[Abstract] |
| 14. | Di Nardo, A., G. Cicchetti, H. Falet, J. H. Hartwig, T. P. Stossel, and D. J. Kwiatkowski. 2005. Arp2/3 complex-deficient mouse fibroblasts are viable and have normal leading-edge actin structure and function. Proc. Natl. Acad. Sci. USA 102:16263-16268. |
| 15. | Ehrlich, J. S., M. D. Hansen, and W. J. Nelson. 2002. Spatio-temporal regulation of Rac1 localization and lamellipodia dynamics during epithelial cell-cell adhesion. Dev. Cell 3:259-270.[CrossRef][Medline] |
| 16. | Erickson, J. W., C. Zhang, R. A. Kahn, T. Evans, and R. A. Cerione. 1996. Mammalian Cdc42 is a brefeldin A-sensitive component of the Golgi apparatus. J. Biol. Chem. 271:26850-26854. |
| 17. | Finlay, B. B. 2005. Bacterial virulence strategies that utilize Rho GTPases. Curr. Top. Microbiol. Immunol. 291:1-10.[Medline] |
| 18. | Gouin, E., M. D. Welch, and P. Cossart. 2005. Actin-based motility of intracellular pathogens. Curr. Opin. Microbiol. 8:35-45.[CrossRef][Medline] |
| 19. | Guillemin, K., N. R. Salama, L. S. Tompkins, and S. Falkow. 2002. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 99:15136-15141. |
| 20. | Harlander, R. S., M. Way, Q. Ren, D. Howe, S. S. Grieshaber, and R. A. Heinzen. 2003. Effects of ectopically expressed neuronal Wiskott-Aldrich syndrome protein domains on Rickettsia rickettsii actin-based motility. Infect. Immun. 71:1551-1556. |
| 21. | Hatakeyama, M. 2003. Helicobacter pylori CagAa potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect. 5:143-150.[CrossRef][Medline] |
| 22. | Higashi, H., A. Nakaya, R. Tsutsumi, K. Yokoyama, Y. Fujii, S. Ishikawa, M. Higuchi, A. Takahashi, Y. Kurashima, Y. Teishikata, S. Tanaka, T. Azuma, and M. Hatakeyama. 2004. Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation. J. Biol. Chem. 279:17205-17216. |
| 23. | Higashi, H., R. Tsutsumi, A. Fujita, S. Yamazaki, M. Asaka, T. Azuma, and M. Hatakeyama. 2002. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. USA 99:14428-14433. |
| 24. | Higashi, H., R. Tsutsumi, S. Muto, T. Sugiyama, T. Azuma, M. Asaka, and M. Hatakeyama. 2002. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295:683-686. |
| 25. | Higuchi, M., R. Tsutsumi, H. Higashi, and M. Hatakeyama. 2004. Conditional gene silencing utilizing the lac repressor reveals a role of SHP-2 in cagA-positive Helicobacter pylori pathogenicity. Cancer Sci. 95:442-447.[CrossRef][Medline] |
| 26. | Hirsch, D. S., D. M. Pirone, and P. D. Burbelo. 2001. A new family of Cdc42 effector proteins, CEPs, function in fibroblast and epithelial cell shape changes. J. Biol. Chem. 276:875-883. |
| 27. | Itoh, R. E., K. Kurokawa, Y. Ohba, H. Yoshizaki, N. Mochizuki, and M. Matsuda. 2002. Activation of rac and cdc42 video imaged by fluorescent resonance energy transfer-based single-molecule probes in the membrane of living cells. Mol. Cell. Biol. 22:6582-6591. |
| 28. | Johnson, D. I. 1999. Cdc42: An essential Rho-type GTPase controlling eukaryotic cell polarity. Microbiol. Mol. Biol. Rev. 63:54-105. |
| 29. | Kraynov, V. S., C. Chamberlain, G. M. Bokoch, M. A. Schwartz, S. Slabaugh, and K. M. Hahn. 2000. Localized Rac activation dynamics visualized in living cells. Science 290:333-337. |
| 30. | Kwok, T., S. Backert, H. Schwarz, J. Berger, and T. F. Meyer. 2002. Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipper-like mechanism. Infect. Immun. 70:2108-2120. |
| 31. | Machesky, L. M., and R. H. Insall. 1998. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr. Biol. 8:1347-1356.[CrossRef][Medline] |
| 32. | Machesky, L. M., R. D. Mullins, H. N. Higgs, D. A. Kaiser, L. Blanchoin, R. C. May, M. E. Hall, and T. D. Pollard. 1999. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex. Proc. Natl. Acad. Sci. USA 96:3739-3744. |
| 33. | Matsumura, F. 2005. Regulation of myosin II during cytokinesis in higher eukaryotes. Trends Cell Biol. 15:371-377.[CrossRef][Medline] |
| 34. | May, R. C., M. E. Hall, H. N. Higgs, T. D. Pollard, T. Chakraborty, J. Wehland, L. M. Machesky, and A. S. Sechi. 1999. The Arp2/3 complex is essential for the actin-based motility of Listeria monocytogenes. Curr. Biol. 9:759-762.[CrossRef][Medline] |
| 35. | Michaelson, D., J. Silletti, G. Murphy, P. D'Eustachio, M. Rush, and M. R. Philips. 2001. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152:111-126. |
| 36. | Miki, H., S. Suetsugu, and T. Takenawa. 1998. WAVE, a novel WASP-family protein involved in actin reorganization induced by Rac. EMBO J. 17:6932-6941.[CrossRef][Medline] |
| 37. | Miki, H., and T. Takenawa. 2003. Regulation of actin dynamics by WASP family proteins. J. Biochem. (Tokyo) 134:309-313. |
| 38. | Mitra, S. K., D. A. Hanson, and D. D. Schlaepfer. 2005. Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell. Biol. 6:56-68.[CrossRef][Medline] |
| 39. | Moese, S., M. Selbach, T. Kwok, V. Brinkmann, W. Konig, T. F. Meyer, and S. Backert. 2004. Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect. Immun. 72:3646-3649. |
| 40. | Moreau, V., F. Frischknecht, I. Reckmann, R. Vincentelli, G. Rabut, D. Stewart, and M. Way. 2000. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat. Cell Biol. 2:441-448.[CrossRef][Medline] |
| 41. | Oh, J. D., S. M. Karam, and J. I. Gordon. 2005. Intracellular Helicobacter pylori in gastric epithelial progenitors. Proc. Natl. Acad. Sci. USA 102:5186-5191. |
| 42. | Parsons, J. T. 2003. Focal adhesion kinase: the first ten years. J. Cell Sci. 116:1409-1416. |
| 43. | Pertz, O., and K. M. Hahn. 2004. Designing biosensors for Rho family proteinsdeciphering the dynamics of Rho family GTPase activation in living cells. J. Cell Sci. 117:1313-1318. |
| 44. | Raftopoulou, M., and A. Hall. 2004. Cell migration: Rho GTPases lead the way. Dev. Biol. 265:23-32.[CrossRef][Medline] |
| 45. | Ridley, A. J., M. A. Schwartz, K. Burridge, R. A. Firtel, M. H. Ginsberg, G. Borisy, J. T. Parsons, and A. R. Horwitz. 2003. Cell migration: integrating signals from front to back. Science 302:1704-1709. |
| 46. | Sanderson, C. M., and G. L. Smith. 1998. Vaccinia virus induces Ca2+-independent cell matrix adhesion during the motile phase of infection. J. Virol. 72:9924-9933. |
| 47. | Sanderson, C. M., M. Way, and G. L. Smith. 1998. Virus-induced cell motility. J. Virol. 72:1235-1243. |
| 48. | Segal, E. D., J. Cha, J. Lo, S. Falkow, and L. S. Tompkins. 1999. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 96:14559-14564. |
| 49. | Selbach, M., S. Moese, C. R. Hauck, T. F. Meyer, and S. Backert. 2002. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J. Biol. Chem. 277:6775-6778. |
| 50. | Stein, M., F. Bagnoli, R. Halenbeck, R. Rappuoli, W. J. Fantl, and A. Covacci. 2002. c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs. Mol. Microbiol. 43:971-980.[CrossRef][Medline] |
| 51. | Straight, A. F., A. Cheung, J. Limouze, I. Chen, N. J. Westwood, J. R. Sellers, and T. J. Mitchison. 2003. Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor. Science 299:1743-1747. |
| 52. | Suetsugu, S., H. Miki, and T. Takenawa. 1999. Identification of two human WAVE/SCAR homologues as general actin regulatory molecules which associate with the Arp2/3 complex. Biochem. Biophys. Res. Commun. 260:296-302.[CrossRef][Medline] |
| 53. | Suzuki, M., H. Mimuro, T. Suzuki, M. Park, T. Yamamoto, and C. Sasakawa. 2005. Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J. Exp. Med. 202:1235-1247. |
| 54. | Szczepanowska, J., E. D. Korn, and H. Brzeska. 2006. Activation of myosin in HeLa cells causes redistribution of focal adhesions and F-actin from cell center to cell periphery. Cell Motil. Cytoskeleton 63:356-374.[CrossRef][Medline] |
| 55. | Tafazoli, F., K. E. Magnusson, and L. Zheng. 2003. Disruption of epithelial barrier integrity by Salmonella enterica serovar Typhimurium requires geranylgeranylated proteins. Infect. Immun. 71:872-881. |
| 56. | Totsukawa, G., Y. Wu, Y. Sasaki, D. J. Hartshorne, Y. Yamakita, S. Yamashiro, and F. Matsumura. 2004. Distinct roles of MLCK and ROCK in the regulation of membrane protrusions and focal adhesion dynamics during cell migration of fibroblasts. J. Cell Biol. 164:427-439. |
| 57. | Tsutsumi, R., A. Takahashi, T. Azuma, H. Higashi, and M. Hatakeyama. 2006. Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell. Biol. 26:261-276. |
| 58. | Uchida, K. S., T. Kitanishi-Yumura, and S. Yumura. 2003. Myosin II contributes to the posterior contraction and the anterior extension during the retraction phase in migrating Dictyostelium cells. J. Cell Sci. 116:51-60. |
| 59. | Unsworth, K. E., M. Way, M. McNiven, L. Machesky, and D. W. Holden. 2004. Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication. Cell. Microbiol. 6:1041-1055.[CrossRef][Medline] |
| 60. | Valderrama, F., J. V. Cordeiro, S. Schleich, F. Frischknecht, and M. Way. 2006. Vaccinia virus-induced cell motility requires F11L-mediated inhibition of RhoA signaling. Science 311:377-381. |
| 61. | Vazquez-Torres, A., J. Jones-Carson, A. J. Baumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804-808.[CrossRef][Medline] |
| 62. | Vogt, A., Y. Qian, T. F. McGuire, A. D. Hamilton, and S. M. Sebti. 1996. Protein geranylgeranylation, not farnesylation, is required for the G1 to S phase transition in mouse fibroblasts. Oncogene 13:1991-1999.[Medline] |
| 63. | Welch, M. D., A. Iwamatsu, and T. J. Mitchison. 1997. Actin polymerization is induced by Arp2/3 protein complex at the surface of Listeria monocytogenes. Nature 385:265-269.[CrossRef][Medline] |
| 64. | Welch, M. D., and R. D. Mullins. 2002. Cellular control of actin nucleation. Annu. Rev. Cell Dev. Biol. 18:247-288.[CrossRef][Medline] |
| 65. | Wennerberg, K., and C. J. Der. 2004. Rho-family GTPases: it's not only Rac and Rho (and I like it). J. Cell Sci. 117:1301-1312. |
| 66. | Wittmann, T., and C. M. Waterman-Storer. 2001. Cell motility: can Rho GTPases and microtubules point the way? J. Cell Sci. 114:3795-3803. |
| |||||||||